← Ticker index
CVS
Ticker
CVS
CVS Health Corporation
Healthcare
Congressional Trades
122
by 24 members
Ticker disclosure brief
Congressional disclosure records for CVS
A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.
Latest receipt
Ro Khanna
BUY · 2026-06-02
Largest range
$100K – $250K
Michael McCaul
Longest observed gap
318d
Valerie Hoyle
Highest 30d vs SPY
76.8%
Julie Johnson
Purchase rows
47
39%
Sale rows
68
56%
Disclosed midpoint
$3.1M
range estimate
Unique Traders
24
members
Disclosure timing method
Observed filing gaps are not notice-date findings
The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.
Party Breakdown
Democrats64 · 52%
Republicans58 · 48%
Lobbying filings
all →- 2026-07-15$60KCVS HEALTHIssues related to pharmaceutical supply chains and patient access. Issues related to Medicare Part D, Medicare Advantage and Medicaid.
- 2026-04-20$3.3MCVS HEALTH (AND SUBSIDIARIES)Issues related to organized retail crime. H.R. 2853/S. 1404, The Combatting Organized Retail Crime Act S. 2068 - The End Prescription Drug Ads Now Act H.R. 3789 - The Drug-price Transparency for Consumers Act of 2025 Issues related to retail pharmacy, drug pricing, and women's health. H.R. 3164 - The Ensuring Community Access to Pharmacist Services Act of 2025 S. 2426 - The Equitable Community Access to Pharmacist Services Act H.R. 5031, The Preserving Patient Access to Long-Term Care Pharmacies Act Issues related to corporate tax. H.R. 3010/S. 1785 - No Handouts for Drug Advertisement Act Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to pharmacy testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. Issues related to Medicaid. S. 882, The Patients Before Middlemen (PBM) Act S. 927, The Protecting Pharmacies in Medicaid Act S. 1105
- 2026-04-20$100KCVS HEALTH INCIssues relating to legislation and regulations affecting Pharmacy Benefit Managers.
- 2026-04-20$60KOAK STREET HEALTH D/B/A CVS HEALTHProvide strategic counsel and advocacy on issues impacting value-based primary care centers for Medicare beneficiaries generally, and Oak Street Healthspecifically
- 2026-04-20$50KCVS HEALTH (AND SUBSIDIARIES)Tracked issues related to pharmacy services, Medicare Advantage and other health issues Tracked issues related to pharmacy services and other health issues.
- 2026-04-20$40KCVS HEALTHIssues related to retail pharmacies, insurance, and Medicare/Medicaid. Issues related to retail pharmacies, insurance, and Medicare/Medicaid. Issues related to retail pharmacies, insurance, and Medicare/Medicaid. Issues related to retail pharmacies, insurance, and Medicare/Medicaid.
- 2026-04-20$30KCVS HEALTHIssues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing.
- 2026-04-17$105KCVS HEALTHfacilitated meetings and discussions regarding the healthcare industry.
- 2026-04-15$70KCVS HEALTH (AND SUBSIDIARIES)Health care policy issues.
- 2026-04-15$60KCVS HEALTHIssues related to pharmaceutical supply chains and patient access. Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Loading trade analytics…
All Disclosed Trades
Page 2 · 25 of 122 shown| Date | Member | Action | Amount | Observed Gap | Receipt |
|---|---|---|---|---|---|
| 2025-10-30 | RLisa McClain | SELL | $1K – $15K | 22d | receipt → |
| 2025-10-31 | RLisa McClain | SELL | $1K – $15K | 21d | receipt → |
| 2025-10-27 | RMichael McCaul | SELL | $15K – $50K | 14d | receipt → |
| 2025-10-27 | RMichael McCaul | SELL | $15K – $50K | 14d | receipt → |
| 2025-09-23 | DValerie Hoyle | SELL | $1K – $15K | 17d | receipt → |
| 2025-09-23 | DValerie Hoyle | SELL | $1K – $15K | 17d | receipt → |
| 2024-10-29 | DValerie Hoyle | BUY | $1K – $15K | 318dApparent delay | receipt → |
| 2024-10-29 | DValerie Hoyle | BUY | $1K – $15K | 318dApparent delay | receipt → |
| 2025-08-22 | RMichael McCaul | SELL | $50K – $100K | 20d | receipt → |
| 2025-08-22 | RMichael McCaul | SELL | $50K – $100K | 20d | receipt → |
| 2025-08-04 | DRo Khanna | BUY | $1K – $15K | 36d | receipt → |
| 2025-08-04 | DRo Khanna | BUY | $1K – $15K | 36d | receipt → |
| 2025-08-08 | DAdam Smith | SELL | $1K – $15K | 0d | receipt → |
| 2025-06-27 | RMichael McCaul | SELL | $100K – $250K | 10d | receipt → |
| 2025-06-27 | RMichael McCaul | SELL | $100K – $250K | 10d | receipt → |
| 2025-05-12 | RJefferson Shreve | SELL | $15K – $50K | 42d | receipt → |
| 2025-05-12 | RJefferson Shreve | SELL | $15K – $50K | 41d | receipt → |
| 2025-05-12 | RJefferson Shreve | SELL | $15K – $50K | 41d | receipt → |
| 2025-05-19 | DRo Khanna | SELL | $1K – $15K | 22d | receipt → |
| 2025-05-28 | DRo Khanna | SELL | $1K – $15K | 13d | receipt → |
| 2025-05-19 | DRo Khanna | SELL | $1K – $15K | 22d | receipt → |
| 2025-05-28 | DRo Khanna | SELL | $1K – $15K | 13d | receipt → |
| 2025-05-15 | RRobert Bresnahan | SELL | $1K – $15K | 18d | receipt → |
| 2025-05-15 | RRobert Bresnahan | SELL | $1K – $15K | 16d | receipt → |
| 2025-05-15 | RRobert Bresnahan | SELL | $1K – $15K | 16d | receipt → |
“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.